Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Takashi Matsumoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6791-6441; OpenAlex author ID A5003021924. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 6

  1. Preoperative Total Iron-Binding Capacity Is a Potential Surrogate Marker of Long-Term Outcomes After Pancreatectomy for Pancreatic Cancer. Co-author DOI 10.1002/ags3.70297↗
  2. High γ-H2AX Predicts Clinical Benefit From Platinum-Based Chemotherapy (mFOLFIRINOX) at Recurrence After Pancreatic Cancer Resection. Co-author DOI 10.1002/jhbp.70032↗
  3. Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.modpat.2025.100865↗
  4. Survival Impact of Perioperative Red Blood Cell Transfusion During Pancreatectomy in Patients With Pancreatic Ductal Adenocarcinoma: A Propensity Score Matchin… Co-author DOI 10.1097/mpa.0000000000001997↗
  5. High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with Pancreatic Cancer: A Retrospective Study. Co-author DOI 10.1245/s10434-022-11500-9↗
  6. Frailty is associated with poor prognosis after resection for pancreatic cancer. Co-author DOI 10.1007/s10147-021-01983-z↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiromitsu Hayashi · 5 shared papers, 2021–2026 · strength 0.97
  2. Yuki Kitano · 3 shared papers, 2022–2026 · strength 0.72
  3. Toru Takematsu · 2 shared papers, 2026 · strength 0.57
  4. Hirohisa Okabe · 2 shared papers, 2026 · strength 0.57
  5. Masaaki Iwatsuki · 2 shared papers, 2026 · strength 0.57
  6. Kosuke Mima · 3 shared papers, 2021–2026 · strength 0.53
  7. Zhao Liu · 2 shared papers, 2022–2026 · strength 0.42
  8. Takayoshi Kaida · 3 shared papers, 2021–2022 · strength 0.40
  9. Katsunori Imai · 3 shared papers, 2021–2022 · strength 0.40
  10. Takanobu Yamao · 1 shared paper, 2026 · strength 0.29
  11. Tatsunori Miyata · 1 shared paper, 2026 · strength 0.29
  12. Taishi Yamane · 1 shared paper, 2026 · strength 0.29
  13. Shinsei Yumoto · 1 shared paper, 2026 · strength 0.28
  14. Rumi Itoyama · 2 shared papers, 2021–2022 · strength 0.26
  15. Hideo Baba · 2 shared papers, 2021–2022 · strength 0.26
  16. Shigeki Nakagawa · 2 shared papers, 2021–2022 · strength 0.25
  17. Shoko Noguchi · 1 shared paper, 2025 · strength 0.24
  18. Kousei Ishigami · 1 shared paper, 2025 · strength 0.24
  19. Yoshinao Oda · 1 shared paper, 2025 · strength 0.24
  20. Nobuhiro Fujita · 1 shared paper, 2025 · strength 0.24
  21. Kohei Nakata · 1 shared paper, 2025 · strength 0.24
  22. Koji Shindo · 1 shared paper, 2025 · strength 0.24
  23. Masafumi Nakamura · 1 shared paper, 2025 · strength 0.24
  24. Akira Chikamoto · 1 shared paper, 2022 · strength 0.15
  25. Hideo Baba · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.